United Services Automobile Association Acquires Shares of 1,555 Waters Corporation $WAT

Key Points

• United Services Automobile Association acquired 1,555 shares of Waters Corporation ($WAT), valued at approximately $563,000, marking a new investment in the medical instruments supplier.
• Waters Corporation recently reported quarterly earnings of $2.95 EPS, exceeding analysts' expectations, with revenue of $771.33 million, reflecting an 8.8% year-over-year growth.
• Analyst ratings for Waters include one Strong Buy, five Buy, and nine Hold ratings, with a consensus target price of $378.73.

United Services Automobile Association bought a new position in shares of Waters Corporation (NYSE:WAT - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 1,555 shares of the medical instruments supplier's stock, valued at approximately $563,000.

Other institutional investors have also recently bought and sold shares of the company. QRG Capital Management Inc. raised its position in Waters by 85.7% in the 1st quarter. QRG Capital Management Inc. now owns 1,642 shares of the medical instruments supplier's stock valued at $605,000 after purchasing an additional 758 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its position in Waters by 4.6% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,986 shares of the medical instruments supplier's stock valued at $1,101,000 after purchasing an additional 130 shares during the last quarter. Janney Montgomery Scott LLC raised its position in Waters by 4.1% in the 1st quarter. Janney Montgomery Scott LLC now owns 4,813 shares of the medical instruments supplier's stock valued at $1,774,000 after purchasing an additional 189 shares during the last quarter. CX Institutional bought a new position in Waters in the 1st quarter valued at $75,000. Finally, Wealth Enhancement Advisory Services LLC raised its position in Waters by 169.1% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 11,619 shares of the medical instruments supplier's stock valued at $4,283,000 after purchasing an additional 7,301 shares during the last quarter. Institutional investors own 94.01% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on WAT. Scotiabank restated a "sector outperform" rating and set a $465.00 target price on shares of Waters in a research report on Friday, July 11th. Robert W. Baird dropped their target price on Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Bank of America boosted their target price on Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Wall Street Zen downgraded Waters from a "buy" rating to a "hold" rating in a research report on Saturday, July 26th. Finally, Jefferies Financial Group set a $385.00 target price on Waters and gave the stock a "buy" rating in a research report on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $378.73.

Waters Trading Down 2.3%

Shares of Waters stock traded down $7.05 during trading on Friday, reaching $295.40. 326,673 shares of the company were exchanged, compared to its average volume of 570,240. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $17.58 billion, a price-to-earnings ratio of 26.64, a P/E/G ratio of 2.82 and a beta of 1.07. The business has a 50-day moving average price of $299.65 and a 200-day moving average price of $333.38.

Waters (NYSE:WAT - Get Free Report) last posted its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $771.33 million during the quarter, compared to analysts' expectations of $745.96 million. During the same period in the previous year, the firm earned $2.63 earnings per share. The company's revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Sell-side analysts anticipate that Waters Corporation will post 12.86 EPS for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.